Clinical trial
Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host…
NCT00472225 · The Korean Society of Hematopoietic Stem Cell Transplantation, Other · Unknown status
Key facts
| NCT number | NCT00472225 |
|---|---|
| Title | Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease |
| Official title | Open-Labelled, Multicenter Phase II Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease |
| Lead sponsor | The Korean Society of Hematopoietic Stem Cell Transplantation, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Steroid-Refractory Chronic GVHD |
| Intervention type | Drug |
| Interventions | Rituximab |
| Enrollment | 42 |
| Start date | May 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2009 |
| First posted | May 11, 2007 |
| Last update posted | Feb 24, 2009 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: